A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender

NCT01687309 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: GSK2586184 800mg single and repeat dose
DRUG: Placebo-to-match GSK2586184
OTHER: GSK2586184 single dose taken with food
OTHER: GSK2586184 single dose taken without food

Sponsor

GlaxoSmithKline